Stryker, a global leader in medical technologies, has announced the launch of its Pangea Plating System, which received FDA clearance in late 2023. Pangea offers a comprehensive and versatile portfolio, providing variable-angle plating for a variety of patient populations.
“The launch of the Pangea Plating System marks a significant milestone for Stryker, our customers and the patients they serve,” said Eric Tamweber, Vice President and General Manager of Stryker’s Trauma business. “With the addition of Pangea, Stryker is the go-to partner for everything trauma – nails, plates, external fixation devices and more, backed by our dedicated team and exceptional service.”
The Pangea Plating System is indicated for the internal fixation and stabilisation of bone fractures, osteotomies and arthrodesis in normal and osteopenic bone. Offering an evidence-based design for implant fit, the system was designed to enhance plate fit and screw placement while elevating the plating market through anatomically contoured implants in patient populations with a wide variety of fracture patterns. The intuitive and streamlined instrumentation and implant trays include 20 anatomic plates and 13 utility plates all accessible in one platform.